Kura Oncology
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $165,804,000.

Profit Margin

Kura Oncology, Inc. (NASDAQ:KURA): Profit margin
2014 0 -11.01M
2015 0 -22.62M
2016 0 -27.56M
2017 0 -35.43M
2018 0 -60.44M
2019 0 -63.14M
2020 0 -89.43M
2021 0 -129.90M
2022 0 -136.06M
2023 0 -152.63M

KURA Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
0000000000
Cost of revenue
849K759K558K194K0030K020K23.90K
Gross profit
-849K-759K-558K-194K00-30K0-20K-23.90K
Operating exp.
Research and development
115.23M92.81M84.72M60.39M47.82M46.78M26.42M20.40M17.77M8.04M
Selling and marketing
0000000000
Total operating expenses
165.80M139.86M131.25M91.89M67.47M62.88M36.07M28.36M23.86M10.90M
Operating income
-165.80M-140.62M-131.81M-92.09M-67.47M-62.88M-36.07M-28.36M-23.86M-11.80M
Other income (expenses), net
13.17M4.78M1.35M2.27M4.33M2.43M943K807K972K879K
Income before tax
-152.63M-135.84M-130.46M-89.62M-63.14M-60.44M-35.43M-27.56M-22.62M-11.01M
Income tax expense
0229K-558K-194K-103.40M-30K-31K-20K268.87K
Net income
-152.63M-136.06M-129.90M-89.43M-63.14M-60.44M-35.43M-27.56M-22.62M-11.01M
Earnings per share
Basic EPS
-2.08-2.03-1.96-1.68-1.51-1.72-1.52-1.47-2.28-78.11
Diluted EPS
-2.08-2.03-1.96-1.68-1.51-1.72-1.52-1.47-2.28-78.11
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source